Latest news
Loading news…
Novozymes
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Bagsværd, Hovedstaden, Denmark Founded 2000 5001-10000 employees For Profit
Novozymes is the world leader in bioinnovation.
Novozymes was acquired by Novonesis in 2022 for $12B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
16
Investments
4
1 exits
Monthly Visits
Available in Pro Contacts
917
Ticker
NSIS B
CPH - Copenhagen Stock Exchange
Patents
2,488
793 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- NSIS B
- Exchange
- CPH - Copenhagen Stock Exchange
- IPO date
- Mar 6, 2024
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 80
- Active products
- 35
- Patents granted
- 2,488
- Trademarks
- 793
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $9M
Investor Activity
- Investments
- 4
- Lead investments
- 1
- Portfolio orgs
- 3
- Exits
- 1
Company Info
- Founded
- 2000
- Employees
- 5001-10000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- Sub-organizations
- 3
- News articles
- 265
- Events
- 1
- HQ
- Bagsværd, Hovedstaden, Denmark
- Region
- European Union (EU), Nordic Countries, Scandinavia
- Exit date
- Mar 6, 2024
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 1.3
- Trend (30d)
- 2.7
- Trend (90d)
- 1.2
- Last leadership hire
- Sep 1, 2025
Investments by Novozymes
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Novozymes
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Novozymes
Vice President, BioAg & Industrial Microbiology
International Commercial Graduate
Group Leader
Executive Vice President and CFO, Corporate Functions
Executive Vice President, Research & Development
Senior Scientist- Technology Innovation Analyst
EVP and CFO
Board of Directors
Global Marketing Director, Food Platforms and Strategic Development
Global Media Relations Manager
Board of Directors
917
professional contacts at Novozymes
Contact execs at Novozymes →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Novozymes
Loading news…
FAQs about Novozymes
People who checked this page also checked these
Sectors Novozymes invests & acquires in
Browse the full Acquirezy directory.